Current Neurologic Drugs
Lippincott Williams and Wilkins (Publisher)
2nd Edition
Published on 1. April 1998
Book
Paperback/Softback
360 pages
978-0-683-30475-6 (ISBN)
Description
This text is designed to provide clinically useful information for the neurologist. Neurologic drugs available in the US are presented by class along with indications, effects and dosages. Included are three indexes: FDA-approved indications, off-label indications, and generic/trade name index.
This text is designed to provide clinically useful information for the neurologist. Neurologic drugs available in the US are presented by class along with indications, effects and dosages. Included are three indexes: FDA-approved indications, off-label indications, and generic/trade name index.
This text is designed to provide clinically useful information for the neurologist. Neurologic drugs available in the US are presented by class along with indications, effects and dosages. Included are three indexes: FDA-approved indications, off-label indications, and generic/trade name index.
More details
Edition
2nd ed.
Language
English
Place of publication
Philadelphia
United States
Target group
College/higher education
Professional and scholarly
Illustrations
160 illustrations
ISBN-13
978-0-683-30475-6 (9780683304756)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Author
Columbia-Presbyterian Medical Center, USA
New York State Psychiatric Institute, USA
Content
Therapeutic agents for cerbrovascular disease; agents for migraine and other headaches; sedative-hypnotics; anti-epileptic drugs; innumosuppressive agents; anti-emetic and antivertigo drugs; anti-dementia agents; opioid agents; general anaesthetics and anaesthesia-associated drugs; agents for treating Parkinson's disease and other movement disorders.